Aplastic Anemia

Aplastic Anemia is a rare blood disorder characterized by a decrease in the production of blood cells. This can lead to a decrease in the number of red blood cells, white blood cells, and platelets. Symptoms include fatigue, shortness of breath, bruising, and frequent infections. It is typically treated with immunosuppressants, bone marrow transplants, and/or blood transfusions. Left untreated, Aplastic Anemia can be fatal. Its significance lies in its rarity, with only about two thousand cases reported in the United States per year, and its prognosis, which is dependent on the severity of the disorder and the specific treatments available. Treatment for Aplastic Anemia requires significant resources, both in terms of cost and personnel. As such, it is a major concern for the medical community, not only for the well-being of individuals diagnosed with the disorder, but also to ensure a competent medical system is able to respond.

← Journal of Skeletal Muscle

Related Articles

4 article(s) found

MicroRNA Profiling of Differentiated, Poorly Differentiated and Anaplastic Thyroid Carcinoma, a Comparative Approach

Full-text HTML Download PDF Download XML

Molecular Study of Hepcidin HAMP (-582A/G) Gene Polymorphisms and Measurement of Serum Hepcidin Level among Sudanese Patients with Anemia of Chronic Kidney Disease

Full-text HTML Download PDF Download XML

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report

Full-text HTML Download PDF Download XML

Prolonged survival of Diamond-Blackfan anemia and RPS19 mutation: an observation in Togo

Full-text HTML Download PDF Download XML